MENEGATTI, Enea
 Distribuzione geografica
Continente #
NA - Nord America 10.523
AS - Asia 5.829
EU - Europa 4.870
SA - Sud America 963
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 92
OC - Oceania 12
Totale 22.394
Nazione #
US - Stati Uniti d'America 10.314
SG - Singapore 2.165
FI - Finlandia 2.055
CN - Cina 1.516
BR - Brasile 750
UA - Ucraina 674
VN - Vietnam 590
IT - Italia 546
HK - Hong Kong 489
DE - Germania 449
GB - Regno Unito 339
TR - Turchia 332
FR - Francia 224
SE - Svezia 188
JP - Giappone 154
IN - India 153
BD - Bangladesh 135
RU - Federazione Russa 134
MX - Messico 83
CA - Canada 81
AR - Argentina 72
IQ - Iraq 51
PL - Polonia 49
CO - Colombia 44
ZA - Sudafrica 42
AT - Austria 33
NL - Olanda 33
ID - Indonesia 32
PK - Pakistan 31
EC - Ecuador 29
ES - Italia 25
LT - Lituania 21
BE - Belgio 19
PH - Filippine 18
RO - Romania 18
SA - Arabia Saudita 18
CL - Cile 16
MY - Malesia 16
VE - Venezuela 16
JO - Giordania 15
UZ - Uzbekistan 15
TH - Thailandia 14
KR - Corea 13
MA - Marocco 13
IL - Israele 12
PE - Perù 11
PY - Paraguay 11
CZ - Repubblica Ceca 10
NP - Nepal 10
CH - Svizzera 9
GR - Grecia 8
IR - Iran 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
DZ - Algeria 7
EG - Egitto 7
JM - Giamaica 7
AZ - Azerbaigian 6
BF - Burkina Faso 6
BO - Bolivia 6
ET - Etiopia 6
GT - Guatemala 6
PT - Portogallo 6
AL - Albania 5
CR - Costa Rica 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PA - Panama 5
DO - Repubblica Dominicana 4
HN - Honduras 4
KW - Kuwait 4
TN - Tunisia 4
TW - Taiwan 4
BH - Bahrain 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
AM - Armenia 2
AO - Angola 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GA - Gabon 2
GE - Georgia 2
MK - Macedonia 2
PR - Porto Rico 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
Totale 22.288
Città #
Helsinki 1.905
Singapore 1.322
Ashburn 1.017
Woodbridge 980
Fairfield 782
Houston 728
Jacksonville 724
Santa Clara 580
San Jose 571
Chandler 565
Hong Kong 469
Ann Arbor 448
Beijing 423
Seattle 302
Wilmington 284
Cambridge 253
Ho Chi Minh City 214
Izmir 205
Nanjing 203
New York 176
Tokyo 147
Los Angeles 145
Hanoi 141
Princeton 141
Dallas 136
Boardman 114
Lauterbourg 111
San Diego 84
Council Bluffs 79
São Paulo 79
Milan 71
Munich 69
Shenyang 63
Mexico City 58
Nanchang 55
Shanghai 52
Hefei 49
Chicago 41
Brooklyn 39
Hebei 39
Tianjin 39
Changsha 37
Warsaw 37
Rome 36
Jiaxing 33
Buffalo 32
Dearborn 32
Rio de Janeiro 32
Denver 31
Montreal 31
London 30
Jinan 29
Baghdad 28
Falkenstein 28
Ferrara 28
Norwalk 27
Orem 27
Chennai 26
Atlanta 25
Frankfurt am Main 25
San Mateo 25
Johannesburg 24
Stockholm 24
Belo Horizonte 23
Mountain View 23
Vienna 23
Da Nang 21
Moscow 21
Poplar 21
Manchester 20
Redwood City 20
Falls Church 19
Kunming 19
Ningbo 19
San Francisco 19
Toronto 19
Guangzhou 18
Haiphong 18
Brussels 17
Turku 17
Auburn Hills 16
Bengaluru 16
Mumbai 16
Ankara 15
Boston 15
Brasília 15
Medellín 15
Philadelphia 14
Tashkent 14
Amman 13
Phoenix 13
Biên Hòa 12
Curitiba 12
Hangzhou 12
Naples 12
Verona 12
Zhengzhou 12
Amsterdam 11
Bangkok 11
Indiana 11
Totale 15.154
Nome #
Microemulsions of retinoids and pharmaceutical compositions containing them 1.971
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 402
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 249
Skin care: The innovative nanotechnology to improve the performance of delivery systems 247
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 236
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 231
Amphiphilic association systems for amphotericin B delivery 230
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 227
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 223
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 222
Clotrimazole Nanoparticle gel for mucosal administration. 222
Respiratory Drug Delivery 221
Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA 220
Amphiphilic association systems for Amphotericin B delivery 218
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 216
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs 214
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 209
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 207
Budesonide microparticles for the treatment of Crohn's disease 205
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 202
Design and characterization of fenretinide containing organogels 202
Microparticles as delivery systems for local delivery to the oral cavity. 201
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 201
Cationic lipid nanosystems as carriers for nucleic acids 200
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 199
Characterization of low -molecular-mass trypsin isoinhibitors from oil-rape (Brassica napus var. oleifera) seed 198
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 197
Influence of formulation and process parameters on pellet production by powder layering technique 196
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 195
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 189
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 186
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 186
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 186
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 185
Eudragit® microparticles for the release of budesonide: A comparative study 185
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 183
Nanosystems for skin hydration: a comparative study 182
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 180
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 180
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 179
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 179
Alginate and cell combination product for wound healing 178
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 177
Characterization of five new low-molecular-mass trypsin inhibitors from white mustard (Sinapis alba L.)seed 177
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 176
Preparation and characterisation of thermoresponsive poly [(N-isopropylacrylamide-co-acrylamide-co(hydroxyethyl acrylate)] microspheres as a matrix for the pulsed release of drugs 174
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 173
Lipid-based supramolecular systems for topical application: A preformulatory study 173
Properties and applications of liposomes in cosmetics 171
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 171
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies 170
Combination of alginate and cells for skin regeneration 169
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 168
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 166
Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate 165
Cross-enzyme inhibition by gabexate mesylate: Formulation and reactivity study 164
Development of polymethacrylic/poloxamer microparticles for topical administration of biotech drugs 163
Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug 162
Colloidal dispersions for the delivery of acyclovir: A comparative study 161
Poly[(N-isopropylacrylamide-co-acrylamide-co-(hydroxyethylmethacrylate)]thermoresponsive microspheres: an accurate method based on solute exclusion technique to determine the volume phase transition temperature 161
Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs 160
In vitro antiproliferative activity of isothiocyanates and nitriles generated by myrosinase-mediated hydrolysis of glucosinolates from seeds of cruciferous vegetables 159
Nasal administration and brain targeting of an antiischemic agent 158
Dextran cross-linked gelatin microspheres as a drug delivery system 158
Preparation and characterization of collagen sponges for dermo-cosmetic applications 158
Liposomes- and ethosomes-associated distamycins: a comparative study 157
Hyaluronan-based microspheres as tools for drug delivery: a comparative study 156
Spray dried Eudragit microparticles as encapsulation devices for vitamin C 156
Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors 155
Preparation and characterization of cationic microspheres for gene delivery 154
Materie Prime: Eccipienti 153
Ethosomes for the delivery of anti-HSV-1 molecules: preparation, characterization and in vitro activity. 152
Production of pellet by powder layering technique: coating with acrylic polymers for enteric drug release 149
NEW DELIVERY SYSTEMS FOR RETINOIDS APPLICATION 148
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 147
Lecithin organogels as cosmetic formulations for methyl nicotinate 146
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 144
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 143
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine 143
Production and characterization of cubosome: a new tool for percutaneous administration of lipophilic drugs 139
Innovative nanotechnology based systems for dermal application 138
Eudragit®/Pluronic nanoparticles for the administration of peptides and proteins 137
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 136
DNA binding activity and inhibition of DNA-protein interactions. Differential effects of tetra-p-amidino-phenoxyneopentane and its 2′-bromo derivative 135
Ethosomes for the delivery of anti-herpetic molecules 132
Lipid-based dispersions for drug delivery 131
Eudragit/Pluronic microparticles for topical administration of peptides and proteins 125
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 122
Niosomes for vaginal administration of an antiherpetic peptide 121
Spray-drying production of trypsin-containing microparticles 120
Peptide-based molecules for the production of positive charged liposomes and micelles 119
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 119
Liposomes and micellar solutions for the delivery of some benzoheterocyclic derivatives of distamycin A 118
In vitro comparison of four anti-inflammatory topical medications 118
Modulation of protease activity by NO-mediated S-nitrosylation. 118
Production and antiproliferative activity of liposomes containing the antitumour drug chromomycin A(3) 117
Diffusion of preservatives from topical dosage forms: A comparative study 117
Oligonucleotide-carrying microspheres. Production, characterization and release characteristics 116
Semisolid formulations based on MAD or NLC for mucosal administration of Clotrimazole 116
Pullulan-cyclodextrin microspheres - A chromatographic approach for the evaluation of the drug-cyclodextrin interactions and the determination of the drug release profiles 115
Totale 19.085
Categoria #
all - tutte 92.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.710
Totale 96.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.209 0 153 114 79 41 52 64 77 36 95 125 373
2022/20231.302 151 48 32 164 221 224 25 130 170 8 88 41
2023/2024623 76 83 24 10 43 114 29 40 8 30 36 130
2024/20252.656 74 41 183 68 385 282 88 152 465 264 391 263
2025/20269.048 698 375 662 1.113 891 471 716 423 2.506 795 253 145
2026/2027465 278 187 0 0 0 0 0 0 0 0 0 0
Totale 22.394